You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. PANK Activators for the treatment of pantothenate kinase-associated neurodegeneration

    SBC: Virtus Therapeutics Corporation            Topic: NINDS

    SUMMARY Pantothenate kinase-associated neurodegeneration, PKAN, is a rare progressive neurodegenerative disorder associated with iron accumulation in the brain. The disease causes early immobility and often death by early adulthood. PKAN is caused by mutations in one of four human pantothenate kinase genes, PANK2 gene, which encodes a mitochondrial pantothenate kinase. Consistent with the clinical ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  2. Nanostructure Array Integrated Medical Mask Design with High Filtration, Low Breathing Resistance, and Antimicrobial Performances

    SBC: 3D ARRAY TECHNOLOGY LLC            Topic: 2

    Herein, 3D Array Technology LLC aims to develop a new type of nanostructure array (nanoarray) integrated microfibers to enable the medical masks with high filtration efficiency, low breathing resistance, and good antimicrobial capabilities. By integrating multifunctional nanoarray coatings onto the polypropylene microfibers through a scalable hydrothermal process, the surface area and roughness of ...

    SBIR Phase I 2022 Department of CommerceNational Institute of Standards and Technology
  3. Leptospirosis Vaccine Development

    SBC: Luna Bioscience, Inc.            Topic: NIAID

    Summary/abstract. Leptospirosis is a globally important neglected disease caused by pathogenic Leptospira. It is estimated to cause more than 1 million global cases annually with a 5-20% case-fatality rate, significant morbidity, and important public health consequences. Currently there is no safe and effective vaccine to prevent human leptospirosis. LeptoX, Inc. proposes to develop the first huma ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Antifungals targeting pantothenate phosphorylation

    SBC: CURATIX, LLC            Topic: NIAID

    SUMMARY Invasive fungal infections (IFIs) create significant healthcare and economic burdens as they are responsible for more than one billion infections worldwide each year resulting in more than 1.5 million deaths. Hospital patients who acquire nosocomial IFIs experience longer hospital stays, increased morbidity, and higher mortality rates. Only a few classes of antifungal drugs are available, ...

    SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  5. DESTRUCTION OF VAM USING A MODULAR CATALYTIC ELEMENT SYSTEM

    SBC: PRECISION COMBUSTION, INC.            Topic: NA

    To eliminate the release of ventilation air methane (VAM) associated with coal production, the core challenge is how to oxidize methane given the low concentrations. Precision Combustion, Inc. (PCI) proposes an innovative modular array combining three key elements: (1) short contact time, low thermal mass reactor design to achieve maximal total conversion in a small volume, (2) catalyst formulati ...

    SBIR Phase I 2022 Department of EnergyARPA-E
  6. Therapeutic Agents Targeting Cryptococcal Infections

    SBC: Quercus Molecular Design, LLC            Topic: NIAID

    Cryptococcus species are a clinically important group of opportunistic fungal pathogens that can cause life threatening disease, particularly in the immunocompromised patient population. Historically, this has involved patients with advanced HIV, but is becoming more prevalent in other immunovulnerable populations. The primary pathogens, C. neoformans and C. gattii, are ubiquitous in the environme ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  7. A Novel Technology to Disseminate WOOP (Wish, Outcome, Obstacle, Plan) to Dementia Caregivers

    SBC: BORROW MY GLASSES LLC            Topic: NIA

    1 Approximately 6.5 million Americans aged 65 and older live with dementia, supported by more than 11 million2 unpaid family caregivers. These numbers are projected to rise exponentially in the coming decades fueling the3 need to develop scalable ways to support dementia caregivers. The need to empower dementia caregivers to4 continue providing care while maintaining their own health and well-bein ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Perennix Mobile Standalone Asset Management System Feasibility Study

    SBC: Perennix. LLC            Topic: AF2310022

    The WCH serious gaming solution can close the gap between DoD civilian healthcare employees and the active-duty/retiree community they serve. By fostering a safe learning environment, culturally sensitive communication skills, and willingness to learn fro

    SBIR Phase I 2023 Department of DefenseAir Force
  9. Simultaneous H2 Generation and Compression with Intermediate-Temperature Solid-Oxide Membranes

    SBC: PRECISION COMBUSTION, INC.            Topic: T7

    Precision Combustion, Inc. (PCI) proposes to develop and demonstrate simultaneous H2 generation and compression with intermediate-temperature solid-oxide membranes. The innovation is based on a novel cell architecture and materials, and processing techniques recently developed at PCI. Proof of concept testing of the new cell architecture indicated potential to be to be lightweight and presents sev ...

    STTR Phase I 2023 National Aeronautics and Space Administration
  10. A Digital Psychoeducational Social Network Intervention for Suicidal Adolescents

    SBC: OUI THERAPEUTICS INC            Topic: 104

    ABSTRACT Suicide is the second leading cause of death among adolescents in the US. Adolescents hospitalized for SI or SA are at risk for future SAs and early mortality; rates of death by suicide may be as high as 10% by 15 years post discharge. Despite these known risks, many suicidal adolescents do not obtain treatment after hospital discharge because there are not enough providers trained to del ...

    SBIR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government